Sjogren's Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome
Condition:   Primary Sjogren's Syndrome Intervention:   Drug: LY3361237 Sponsor:   Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome
Condition:   Primary Sjogren's Syndrome Interventions:   Biological: Telitacicept 80 mg;   Biological: Telitacicept 160 mg;   Drug: Placebo Sponsor:   RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2023 Category: Research Source Type: clinical trials